agilon health, inc. AGL
NYSE · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2021-04-15
agilon health, inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.9B | $6.1B | $4.3B | $2.4B | $1.5B | $1.2B |
| Operating income | -$463.2M | -$292.1M | -$232.1M | -$105.4M | -$372.2M | -$56.7M |
| Interest expense | — | — | $6.7M | $4.5M | $6.1M | $8.1M |
| Income tax | $1.3M | $1.5M | $791,000 | $1.6M | $886,000 | $865,000 |
| Net income | -$391.3M | -$260.2M | -$262.6M | -$106.6M | -$406.5M | -$60.1M |
| Operating cash flow | -$105.8M | -$57.8M | -$156.2M | -$130.8M | -$148.2M | -$53.2M |
| Free cash flow | -$119.0M | -$71.0M | -$172.0M | -$146.2M | -$154.7M | -$55.0M |
| Cash & equivalents | $173.7M | $188.2M | $107.6M | $465.3M | $1.0B | $106.8M |
| Total assets | $1.3B | $1.7B | $1.7B | $1.7B | $1.6B | $446.4M |
| Total liabilities | $1.1B | $1.3B | $1.1B | $656.9M | $494.7M | $421.6M |
| Shareholders' equity | $126.7M | $471.0M | $661.8M | $1.0B | $1.1B | -$284.7M |
Growth · year-over-year · Revenue CAGR 37.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | -2.1% | +40.4% | +80.7% | +57.0% | +24.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.